CDKN2A and acute lymphoblastic leukemia: In BCR-ABL transformed cells, JUN activation prevents CDK6 promoter methylation which is a limiting factor for leukemogenesis [111] and finally in 30% to 50% Ph+ ALL cases the CDKN2A locus is deleted, removing the inhibition of CDK6 by p16-INK4A [63,65].